63 related articles for article (PubMed ID: 36436290)
1. Modeling the COVID Pandemic: Do Delays in Surgery Justify Using Stereotactic Radiation to Treat Low-Risk Early Stage Non-Small Cell Lung Cancer?
Cao L; Linden PA; Biswas T; Worrell SG; Sinopoli JN; Miller ME; Shenk R; Montero AJ; Towe CW
J Surg Res; 2023 Mar; 283():532-539. PubMed ID: 36436290
[TBL] [Abstract][Full Text] [Related]
2. Wedge Resection versus Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors ≤8 mm.
Mansur A; Saleem Z; Beqari J; Mathey-Andrews C; Potter AL; Cranor J; Nees AT; Srinivasan D; Yang ME; Yang CJ; Auchincloss HG
Curr Oncol; 2024 Mar; 31(3):1529-1542. PubMed ID: 38534949
[TBL] [Abstract][Full Text] [Related]
3. Shortage of thoracic surgeons in the United States: Implications for treatment and survival for stage I lung cancer patients.
Potter AL; Rosenstein AL; Kandala K; Venkateswaran S; Kiang MV; Okusanya OT; Auchincloss HG; Martin LW; Colson YL; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2024 May; 167(5):1603-1614.e9. PubMed ID: 37716651
[TBL] [Abstract][Full Text] [Related]
4. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a-b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery.
Henschke CI; Yip R; Sun Q; Li P; Kaufman A; Samstein R; Connery C; Kohman L; Lee P; Tannous H; Yankelevitz DF; Taioli E; Rosenzweig K; Flores RM; ;
J Thorac Oncol; 2024 Mar; 19(3):476-490. PubMed ID: 37806384
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of Lymphocyte CD44 in Determining Treatment Selection Between Stereotactic Body Radiation Therapy and Surgery for Early-Stage Non-Small Cell Lung Cancer.
Yan W; Ren Z; Chen X; Zhang R; Lv J; Verma V; Wu M; Chen D; Yu J
Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38447611
[TBL] [Abstract][Full Text] [Related]
6. Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT.
Liu Q; Medina HN; Rodriguez E; Jacobs KT; Brown C; Koru-Sengul T; Lopes G; Pinheiro PS
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):489-499. PubMed ID: 38252069
[TBL] [Abstract][Full Text] [Related]
7. Timely Curative Treatment and Overall Mortality Among Veterans With Stage I NSCLC.
Sanchez R; Vaughan Sarrazin MS; Hoffman RM
JTO Clin Res Rep; 2023 Feb; 4(2):100455. PubMed ID: 36908685
[TBL] [Abstract][Full Text] [Related]
8. Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?
Sroufe R; Kong FM
Transl Lung Cancer Res; 2015 Aug; 4(4):438-47. PubMed ID: 26380185
[TBL] [Abstract][Full Text] [Related]
9. Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian Perspective.
Agulnik J; Kasymjanova G; Pepe C; Friedmann J; Small D; Sakr L; Wang H; Spatz A; Sultanem K; Cohen V
Curr Oncol; 2024 Mar; 31(3):1562-1571. PubMed ID: 38534952
[No Abstract] [Full Text] [Related]
10. Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care.
Zhai Y; Chopra P; Kang D; Robert NJ; Zhang W
Curr Oncol; 2023 Jan; 30(1):769-785. PubMed ID: 36661708
[TBL] [Abstract][Full Text] [Related]
11. Analyzing the impact of the Coronavirus disease 2019 pandemic on initial oncologic presentation and treatment of non-small cell lung cancer in the United States.
Dyas AR; Bronsert MR; Stuart CM; Thomas MB; Schulick RD; Franco SR; Gleisner A; Randhawa SK; David EA; Mitchell JD; Meguid RA
J Thorac Cardiovasc Surg; 2023 Nov; ():. PubMed ID: 37981103
[TBL] [Abstract][Full Text] [Related]
12. Disparate impact of the COVID-19 pandemic on delays in colorectal cancer treatment: A National Cancer Database study.
Chung SH; Rasic G; Romatoski KS; Kenzik K; Tseng JF; Sachs TE
Surgery; 2024 Apr; 175(4):1013-1020. PubMed ID: 38245445
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Optimal Time Between Diagnosis and Surgical Intervention for Early-Stage Lung Cancer.
Bassiri A; Badrinathan A; Alvarado CE; Kwak M; Sinopoli J; Tapias Vargas L; Linden PA; Towe CW
J Surg Res; 2023 Dec; 292():297-306. PubMed ID: 37683454
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Outcomes of COVID-19 Pandemic on Non-Small Cell Lung Cancer Screening and Management.
Orelaru F; Edwards M; Raleigh R; Abunayla A; Bush R; Porter S; Schumaker K; Albright J; Adams KN
Surg J (N Y); 2023 Oct; 9(4):e156-e161. PubMed ID: 38197091
[No Abstract] [Full Text] [Related]
15. Barriers to Timely Lung Cancer Care in Early Stage Non-Small Cell Lung Cancer and Impact on Patient Outcomes.
Pirzadeh M; Lagina M; Wood C; Valley T; Ramnath N; Arenberg D; Deng JC
Clin Lung Cancer; 2024 Mar; 25(2):135-143. PubMed ID: 37981476
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 Pandemic on Advanced Non-small Cell Lung Cancer Treatment at a Japanese Hospital.
Miyazaki K; Kodama T; Aida Y; Sato S; Satoh H
Cancer Diagn Progn; 2023; 3(6):716-720. PubMed ID: 37927803
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative body radiation therapy or surgery for operable early non-small cell lung cancer patients: bound hand and foot to evidence.
Levy A; Mercier O; Le Péchoux C
J Thorac Dis; 2017 Mar; 9(3):482-484. PubMed ID: 28449450
[No Abstract] [Full Text] [Related]
18. Discussion to: Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.
J Thorac Cardiovasc Surg; 2024 Mar; 167(3):834-835. PubMed ID: 37865894
[No Abstract] [Full Text] [Related]
19. Surgical Resection Delays among Patients with Stage 1 Lung Cancer: A Study with Disaggregated Ethnic Groups.
Kazzi B; Mankuzhy NP; Swami N; Jain B; Patel TA; Chan JSK; Lam MB; Tian S; Dee EC
Ann Surg Oncol; 2024 May; 31(5):2818-2823. PubMed ID: 38282026
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
